The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Vor Biopharma Inc’s current trading price is -44.72% away from its 52-week high, while its distance from the 52-week low is 1287.26%. The stock’s price range for this period has been between $0.13 and $3.29 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.22 million for the day, a number notably lower than the average daily volume of 18.17 million over the last three months.
The present stock price for Vor Biopharma Inc (VOR) is $1.82. In the last trading session, the stock made a considerable jump, reaching $3.0 after an opening price of $1.78. The stock briefly fell to $0.3 before ending the session at $1.99.
Vor Biopharma Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $3.29 on 07/08/25, while the lowest price for the same period was registered at $0.13 on 05/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Vor Biopharma Inc (VOR) has experienced a quarterly rise of 954.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 230.32M and boasts a workforce of 159 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9850, with a change in price of +0.9867. Similarly, Vor Biopharma Inc recorded 11,777,105 in trading volume during the last 100 days, posting a change of +116.91%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VOR stands at 0.47. Similarly, the long-term debt-to-equity ratio is also 0.40.
VOR Stock Stochastic Average
Vor Biopharma Inc’s raw stochastic average for the past 50 days is presently 53.06%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 3.61%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.45% and 16.49%, respectively.
VOR Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 118.86% this year. Over the last six months, there has been a weaker performance of 31.79%. The price of VOR leaped by -23.90% during the last 30 days period. For the last 5-days stocks have slided -16.57%.
